Phillip Gross, 10% Owner at Praxis Precision Medicines, Inc. (PRAX), sold 301,310 shares at $91.04 ($32.1M) on 2025-10-16, disclosed to the SEC on 2025-10-17.
Scheduled sale ($32.1M) by 10% Owner.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.04 | 447 | $41K | 0.1% |
| 2 | $92.03 | 1,363 | $125K | 0.4% |
| 3 | $100.11 | 559 | $56K | 0.2% |
| 4 | $101.00 | 27,287 | $2.8M | 8.6% |
| 5 | $104.31 | 250,000 | $26.1M | 81.3% |
| 6 | $130.10 | 1,661 |
| $216K |
| 0.7% |
| 7 | $131.64 | 487 | $64K | 0.2% |
| 8 | $132.19 | 308 | $41K | 0.1% |
| 9 | $140.00 | 19,198 | $2.7M | 8.4% |
| Total | $106.42 avg | 301,310 | $32.1M | 100% |
| Filing → |
| CALA | BUY | 2015-08-28 | $908K | — | Filing → |
| ADXS | BUY | 2015-08-24 | $4.2M | — | Filing → |
| ADXS | BUY | 2015-05-04 | $9.5M | — | Filing → |